Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2022-08-15 00:00:00 ET · period of report 2022-08-13 · accession 0001628280-22-022907 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-08-15 | 2022-08-13 | MYGN | DIAZ PAUL J | Pres, CEO, Dir | F - Tax | $27.61 | -72.3K | 1.14M | -6% | -$2.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-13 | F | D | 49,980 | $27.61 | 1,087,079 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-13 | F | D | 22,370 | $27.61 | 1,137,059 | D | — | — |